High%20Risk%20Multiple%20Myeloma
Showing 9976 - 10000 of >10,000
Myeloproliferative Tumor (MPN), Myelofibrosis,MF Trial (flonoltinib 25mg, flonoltinib 50mg, flonoltinib 100mg)
Not yet recruiting
- Myeloproliferative Neoplasm (MPN)
- Myelofibrosis,MF
- flonoltinib 25mg
- +5 more
- (no location specified)
Nov 2, 2021
Monocytes Sub-populations in Thrombosis Associated With
Recruiting
- Myeloproliferative Neoplasm
- 1 additional tube of blood
-
Bordeaux, France
- +4 more
Nov 30, 2022
Venous Thromboembolism, Venous Thromboses, Pulmonary Embolism Trial in Netherlands (Randomised treatment advice (discontinue vs
Recruiting
- Venous Thromboembolism
- +3 more
- Randomised treatment advice (discontinue vs continue after 3 months)
- +4 more
-
Leiden, South-Holland, Netherlands
- +16 more
Oct 17, 2023
Neurologic Diseases, Arthropathy of Knee, Arthropathy of Hip Trial in Pavia (Multidisciplinary Conventional Neuromotor
Recruiting
- Neurologic Diseases
- +2 more
- Multidisciplinary Conventional Neuromotor Rehabilitation
- Technology-based Rehabilitation
-
Pavia, PV, ItalyIstituti Clinici Scientifici Maugeri, IRCCS
May 26, 2022
Atopic Dermatitis Trial in Ilsan, Seoul (FURESTEM-AD inj)
Recruiting
- Atopic Dermatitis
- FURESTEM-AD inj
-
Ilsan, Korea, Republic of
- +1 more
Jan 10, 2022
Fetal Monitoring, Non-invasive, Cardiotocography Trial in Veldhoven (eCTG monitoring with the NFMS)
Not yet recruiting
- Fetal Monitoring
- +4 more
- eCTG monitoring with the NFMS
-
Veldhoven, Noord-Brabant, NetherlandsMaxima MC
Nov 16, 2023
SDCC - Prospective Cohort Study of Chronic Renal Insufficiency
Active, not recruiting
- Renal Insufficiency, Chronic
-
Oakland, California
- +11 more
May 16, 2022
Non Small Cell Lung Cancer Trial in Worldwide (Nivolumab, Cisplatin, Vinorelbine)
Active, not recruiting
- Non Small Cell Lung Cancer
- Nivolumab
- +8 more
-
Glendale, Arizona
- +135 more
Feb 28, 2022
Multiple Sclerosis Trial in Roma, Rome (Cognitive Rehabilitation, Combined Rehabilitation, Motor Rehabilitation)
Completed
- Multiple Sclerosis
- Cognitive Rehabilitation
- +2 more
-
Roma, Rm, Italy
- +1 more
Jul 14, 2022
Multiple Myeloma Trial in Atlanta, New York (bortezomib (Velcade), cyclophosphamide, G-CSF)
Completed
- Multiple Myeloma
- bortezomib (Velcade)
- +3 more
-
Atlanta, Georgia
- +4 more
Dec 18, 2019
Vis-Rx Post-Market Evaluation
Recruiting
- Coronary Artery Disease
- HF-OCT Imaging with the Vis-Rx Micro-Imaging Catheter
-
Tampa, Florida
- +2 more
Jan 13, 2023
Cancer Trial in Wiener Neustadt (Particle radiotherapy, Magnetic resonance imaging, Computertomography)
Recruiting
- Cancer
- Particle radiotherapy
- +5 more
-
Wiener Neustadt, Niederösterreich, AustriaEBG MedAustron GmbH
Dec 1, 2022
Lung Cancer Trial in Boston, Nashville
Active, not recruiting
- Lung Cancer
-
Boston, Massachusetts
- +1 more
Dec 28, 2022
Metastatic Colorectal Cancer, Chemo Effect, Peritoneal Metastases Trial in Lund, Malmö (Chemotherapy, Resection of the primary
Recruiting
- Metastatic Colorectal Cancer
- +4 more
- Chemotherapy
- +3 more
-
Lund, Skåne, Sweden
- +1 more
Mar 6, 2023
d in the Treatment of Multiple Sclerosis
Not yet recruiting
- Multiple Sclerosis
- Measurement of concentrations of orally-used DMDs
- +3 more
-
Ostrava, Moravian-Silesian Region, Czechia
- +1 more
Dec 5, 2022
Patients at Risk for Chronic Graft-Versus-Host Disease
Not yet recruiting
- cGVHD
- Non-Interventional
- (no location specified)
Jun 16, 2023
Myocardial Perfusion by Cardiac CT in Patients
Suspended
- Coronary Disease
- Aortic Valve Stenosis
-
Graz, Austria
- +2 more
Jul 12, 2021
Laparoscopic Donor Nephrectomy Trial in Loma Linda (Percuvance™ Percutaneous Surgical System)
Terminated
- Laparoscopic Donor Nephrectomy
- Percuvance™ Percutaneous Surgical System
-
Loma Linda, CaliforniaLoma Linda Medical Center
Nov 16, 2022
Bladder Cancer, Radical Cystectomy Trial (Preop Intervention and Monitored Recovery, Usual Care)
Not yet recruiting
- Bladder Cancer
- Radical Cystectomy
- Preop Intervention and Monitored Recovery
- Usual Care
- (no location specified)
Jan 26, 2023
Prodromal and Overt Parkinson's Disease Epidemiological Study in
Recruiting
- Parkinson Disease
- Parkinsonism
-
Salvador, Bahia, Brazil
- +3 more
Dec 22, 2022
TRACK-MSA: A Longitudinal Study to Define Outcome Measures in
Recruiting
- Multiple System Atrophy
-
New York, New YorkNYU Langone Medical Center
Jun 3, 2022
Cardiopulmonary and Right Ventricular Function in Health and
Recruiting
- Heart Failure
- Athletes Heart
-
Aurora, ColoradoUniversity of Colorado
Aug 19, 2021
COVID-19 and Multiple Sclerosis Disease Modifying Therapies
Enrolling by invitation
- Covid19
- Multiple Sclerosis
-
Nottingham, Nottinghamshire, United KingdomNottingham University Hospitals NHS Trust
Apr 27, 2021
Language Development Disorders Trial in Clermont-Ferrand (acoustic otoemisions, Otoscopy, Audiometry)
Not yet recruiting
- Language Development Disorders
- acoustic otoemisions
- +3 more
-
Clermont-Ferrand, FranceCHU Clermont-Ferrand, UMR INSERM 1107
Nov 21, 2022